MESENCHYMAL STEM CELLS

There is a great deal of conversation happening around mesenchymal stem cells, more accurately known as medicinal signaling cells, or MSC's. In fact, many in the scientific community posit, based on verified clinical trial data, that MSC-based therapies offer a promising approach for the treatment of COVID-19 patients... During 30 years of scientific inquiry, Dr. Caplan and colleagues discovered that MSCs are more accurately medicinal signaling cells that monitor and protect virtually every vessel in our bodies. That encompasses 60,000-100,000 miles of vessels that transport oxygen, nutrition and waste to and from every one of our cells. When an MSC (or its precursor) detects an infection or an injury to those vessels, it transforms into a bio-factory to secrete and recruit immune modulating and vessel repair agents... MSCs were first commercialized by Dr. Caplan when he partnered with Peter Freidli, serial entrepreneur Kevin Kimberlin and Spencer Trask & Co. Together they launched..